The latest trading day saw Bristol Myers Squibb (BMY) settling at $56.29, representing a -0.16% change from its previous close.
Semaglutide (Ozempic) is 1 of 15 medications that will be included in yearly price negotiations between Medicare and ...
Amgen’s Lumakras and AstraZeneca’s Calquence are both in line to expand their respective oncology reaches with new FDA ...
Jefferies has recently raised Bristol-Myers Squibb Co (BMY) stock to Buy rating, as announced on December 16, 2024, according to Finviz. Earlier, on December 10, 2024, BofA Securities had resumed the ...
Fans of cleaning guru Mrs Hinch have shared their top tips for getting rid of limescale and black stains on your shower head, ...